In financial accounting, a balance sheet is a summary of the financial balances of an individual or organization, whether it be a sole proprietorship, a business partnership, a corporation, private limited company or other organization such as government or not-for-profit entity.
Botanix Pharmaceuticals Limited Balance Sheet Statement - Assets
As of 30 Jun 2025, The total current assets of Botanix Pharmaceuticals Limited (ASX:BOT) was around $99,586,567 which consisted of $64,966,581 of Cash, $28,075,635 of Inventory and $3,203,926 of Net receivables. Current assets represent all the assets of a company that are expected to be conveniently sold, consumed, used, or exhausted through standard business operations within one year.
All amounts in AUD
The latest balance sheet of Botanix Pharmaceuticals Limited also showed $1,384,219 of Property Plant Equipment and no Good will. Also there were $28,124,554 of Intangible assets and no Other assets. The total assets including current and Intangibles/Deferred Long Term Asset Charges were $129,095,340.
Botanix Pharmaceuticals Limited Balance Sheet Statement - Liabilities
BOT's latest annual results shows the balance sheet has $8,869,227 of Accounts Payable. Also there were $32,106,202 of Short/Long term debt, $22,065,528 of Long term debt, no Other Current liabilities and $24,921,335 of Total Current Liabilities. Current liabilities are a company's short-term financial obligations that are due within one year or within a normal operating cycle.
As per the 30 Jun 2025's annual report of Botanix Pharmaceuticals Limited, the total liabilities were $47,796,411.
BOT Balance Sheet Statement - Stock Holder Equity
Stockholders' equity, also referred to as shareholders' equity, is the remaining amount of assets available to shareholders after all liabilities have been paid. It is calculated either as a firm's total assets less its total liabilities or alternatively as the sum of share capital and retained earnings less treasury shares. Stockholders' equity might include common stock, paid-in capital, retained earnings and treasury stock.
The latest Balance sheet of Botanix Pharmaceuticals Limited showed the total stock holder equity was $81,298,929 which consisted of $226,301,989 of Common stocks, $-177,187,827 of Retained earnings and no Other stock holder equity.
BOT Balance Sheet Statement History
Following table shows the history of balance sheet for Botanix Pharmaceuticals Limited (BOT).
| 30 Jun 2025 | 30 Jun 2024 | 30 Jun 2023 | 30 Jun 2022 | 30 Jun 2021 | |
|---|---|---|---|---|---|
| Cash | 64,966,581 | 79,308,130 | 10,250,395 | 7,285,653 | - |
| Net Receivables | 3,203,926 | 817,038 | 489,124 | 140,824 | - |
| Inventory | 28,075,635 | 1,209,374 | 3,147,031 | 6,088,694 | - |
| Total Current Assets | 99,586,567 | 82,901,306 | 13,978,628 | 13,545,563 | - |
| Property Plant Equipment | 1,384,219 | 71,777 | 65,376 | -157,754 | - |
| Good Will | - | - | - | - | - |
| Intangible Assets | 28,124,554 | 29,491,543 | 10,729,375 | 6,590,492 | - |
| Other Assets | - | - | - | - | - |
| Deferred Long Term Asset Charges | - | - | - | - | - |
| Total Assets | 129,095,340 | 112,464,626 | 24,836,023 | 20,101,713 | - |
| Accounts Payable | 8,869,227 | 2,728,365 | 1,390,702 | 5,667,708 | - |
| Short/Long Term Debt | 32,106,202 | - | - | 122,414 | 259,318 |
| Other Current Liabilities | - | - | - | - | - |
| Long Term Debt | 22,065,528 | - | - | - | - |
| Other Liabilities | - | - | - | - | - |
| Total Current Liabilities | 24,921,335 | 3,732,077 | 1,884,996 | 6,871,527 | - |
| Total Liabilities | 47,796,411 | 3,732,077 | 1,884,996 | 6,871,527 | - |
| Common Stock | 226,301,989 | 188,320,331 | 93,489,658 | 71,475,764 | - |
| Retained Earnings | -177,187,827 | -90,791,641 | -76,921,932 | -67,767,958 | - |
| Treasury Stock | - | - | - | - | - |
| Other Stockholder Equity | - | - | - | - | - |
| Total Stockholder Equity | 81,298,929 | 108,732,549 | 22,951,027 | 8,151,777 | - |
| Net Tangible Assets | 53,174,375 | 79,241,006 | 12,221,652 | 1,561,285 | - |
Botanix Pharmaceuticals Limited (ASX:BOT) Balance Sheet Statement FAQ
1. How much Cash Botanix Pharmaceuticals Limited has on their balance sheet?
As of 30 Jun 2025, Botanix Pharmaceuticals Limited (ASX:BOT) has $64,966,581 of Cash.
2. What's the long term debt of Botanix Pharmaceuticals Limited?
As per the latest Balance sheet of Botanix Pharmaceuticals Limited (ASX:BOT), it has $22,065,528 of Long term debt.
3. How much share holder equity does Botanix Pharmaceuticals Limited has?
The Botanix Pharmaceuticals Limited (ASX:BOT)'s balance sheet shows that it has $81,298,929 of Total stock holder equity.